Biometry
Boston · Founded 2013
About Biometry
Biometry is a health technology company that develops connected diagnostics and monitoring tools to support patients with chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its platform combines patented breath sensors that measure airway inflammation biomarkers with an analytics engine to generate risk assessments, personalized risk profiles, and insights into symptom triggers and treatment response. Biometry’s solution integrates real-time biomarker data with clinical and environmental factors through a mobile app to help users and clinicians understand disease control and anticipate exacerbations. The technology is designed to enable proactive self-management and support preventive care by identifying changes in risk before symptoms worsen. The company also provides guideline-based coaching and educational content delivered through its platform to assist users in improving long-term disease control. Its products are in development and focus on enabling connected, data-driven approaches for respiratory health management.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.8M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: https://www.mybiometry.com
Industries & Categories
Analytics, Artificial Intelligence (AI), Biotechnology, Medical Device, Software
Social Profiles
Canonical: https://fsome.com/organization/biometry-75399 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.